# Wendy M. Blumenschein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wendy-m-blumenschein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,228 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 33 |
| i10-index | 42 |
| Last Known Institution | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| OpenAlex ID | https://openalex.org/A5082665065 |
| ORCID iD | https://orcid.org/0009-0007-1175-9361 |
| Works | 95 |

## Researcher papers

- [IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis](https://scholariq.org/papers/il-23-stimulates-epidermal-hyperplasia-via-tnf-and-il-20r2-dependent-mechanisms/)
- [Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study](https://scholariq.org/papers/pembrolizumab-in-patients-with-thymic-carcinoma-a-single-arm-single-centre-phase/)
- [T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas](https://scholariq.org/papers/t-cell-infiltration-and-clonality-correlate-with-programmed-cell-death-protein-1/)
- [Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma](https://scholariq.org/papers/randomized-phase-ii-and-biomarker-study-of-pembrolizumab-plus-bevacizumab-versus/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [Merck & Co., Inc., Rahway, NJ, USA (United States)](https://scholariq.org/institutions/merck-and-co-inc-rahway-nj-usa-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.